Literature DB >> 2387573

Intraglandular tumor extent and prognosis in prostatic carcinoma: application of a grid method to prostatectomy specimens.

P A Humphrey1, R T Vollmer.   

Abstract

The extent of tumor in prostatectomy specimens was determined by a grid method in 117 patients with prostatic adenocarcinoma. A plastic strip or ruler with squares of 3.0 mm was used, and the ratio of squares overlying carcinoma to the total number of squares overlying prostate tissue was calculated. This grid ratio, which represents an estimate of the percentage of the prostate involved by tumor, was a significant prognosticator closely tied to the likelihood of tumor progression and to survival time, as assessed by logistic regression analysis and a proportional hazard model. The grid ratio was better than histologic grade in predicting tumor progression and patient survival; also, the ratio was more objective than histologic grade as judged by interobserver agreement values. Only slight improvement in prognostication was obtained with concurrent use of both extent and grade. The grid ratio method was slightly better in predicting tumor progression and patient survival than a second method of assessing the percentage of prostatic tissue involved by tumor, the pathologist's percentage estimate. These results indicate that it is important to quantitate tumor extent within prostatectomy specimens; such quantitation need not require step-sectioning of the entire prostate and an expensive and time-consuming method such as computerized morphometrics but rather may be performed by a simple estimate of the percentage of the prostate involved by tumor. Reporting of histologic grade and tumor extent in the prostate gland is recommended as both appear to be important in identifying those patients at risk for a poor outcome after prostatectomy for prostatic carcinoma.

Entities:  

Mesh:

Year:  1990        PMID: 2387573     DOI: 10.1016/0046-8177(90)90048-a

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  13 in total

1.  Prevalence of incidental prostate cancer in patients undergoing radical cystoprostatectomy: data from China and other Asian countries.

Authors:  Yi-Ping Zhu; Ding-Wei Ye; Xu-Dong Yao; Shi-Lin Zhang; Bo Dai; Hai-Liang Zhang; Yi-Jun Shen; Yao Zhu; Guo-Hai Shi
Journal:  Asian J Androl       Date:  2008-12-01       Impact factor: 3.285

2.  A Novel System for Estimating Residual Disease and Pathologic Response to Neoadjuvant Treatment of Prostate Cancer.

Authors:  Claire Murphy; Lawrence True; Funda Vakar-Lopez; Jing Xia; Roman Gulati; Bruce Montgomery; Maria Tretiakova
Journal:  Prostate       Date:  2016-06-08       Impact factor: 4.104

Review 3.  Evaluating radical prostatectomy specimens: therapeutic and prognostic importance.

Authors:  D G Bostwick; R Montironi
Journal:  Virchows Arch       Date:  1997-01       Impact factor: 4.064

4.  The prognostic significance of percentage of tumour involvement according to disease risk group in men treated with radical prostatectomy.

Authors:  Jong Jin Oh; Sang Cheol Lee; Chang Wook Jeong; Cheol Yong Yoon; Seong Jin Jeong; Sung Kyu Hong; Seok-Soo Byun; Yoon Kwan Rho; Gheeyoung Choe; Sang Eun Lee
Journal:  Asian J Androl       Date:  2011-09-26       Impact factor: 3.285

5.  The influence of extent of surgical margin positivity on prostate specific antigen recurrence.

Authors:  R E Emerson; M O Koch; T D Jones; J K Daggy; B E Juliar; L Cheng
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

6.  In Organ-confined Prostate Cancer, Tumor Quantitation Not Found to Aid in Prediction of Biochemical Recurrence.

Authors:  Yujiro Ito; Emily A Vertosick; Daniel D Sjoberg; Andrew J Vickers; Hikmat A Al-Ahmadie; Ying-Bei Chen; Anuradha Gopalan; Sahussapont J Sirintrapun; Satish K Tickoo; James A Eastham; Peter T Scardino; Victor E Reuter; Samson W Fine
Journal:  Am J Surg Pathol       Date:  2019-08       Impact factor: 6.394

7.  Prostate cancer with bladder neck involvement: pathologic findings with application of a new practical method for tumor extent evaluation and recurrence-free survival after radical prostatectomy.

Authors:  Athanase Billis; Leandro L L Freitas; Luis A Magna; Adil B Samara; Ubirajara Ferreira
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

8.  The presence of benign prostatic glandular tissue at surgical margins does not predict PSA recurrence.

Authors:  K M Kernek; M O Koch; J K Daggy; B E Juliar; L Cheng
Journal:  J Clin Pathol       Date:  2005-07       Impact factor: 3.411

9.  Magnetic resonance diffusion characteristics of histologically defined prostate cancer in humans.

Authors:  Junqian Xu; Peter A Humphrey; Adam S Kibel; Abraham Z Snyder; Vamsidhar R Narra; Joseph J H Ackerman; Sheng-Kwei Song
Journal:  Magn Reson Med       Date:  2009-04       Impact factor: 4.668

10.  Pretreatment tumor volume estimation based on total serum psa in patients with localized prostate cancer.

Authors:  Raphael Barroso Kato; Victor Srougi; Fernanda Aburesi Salvadori; Pedro Paulo Marino Rodrigues Ayres; Katia Moreira Leite; Miguel Srougi
Journal:  Clinics (Sao Paulo)       Date:  2008-12       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.